Q3-2019 Pharmacy Infusion Services Update – Deals continue to occur in both traditional areas of pharmacy services such as retail and LTC, as well as new, emerging verticals such as health system specialty pharmacy services.
Q2-2019 Pharmacy Infusion Services Update – Transaction activity occurred within multiple sub-sectors of pharmacy services including LTC, infusion therapy, and specialty. Given the historical and future growth trajectory of the space, consolidation and investment activity is expected to continue for the foreseeable future.
Consolidation in Outsourced Pharmaceutical Services– Contract Research Organizations (CROs) and Contract Development & Manufacturing Organizations (CDMOs) are utilizing strategic mergers, acquisitions, and private equity partnerships to capitalize on tailwinds in the outsourced pharmaceutical services sector.
Q1-2019 Pharmacy Services Update – Private equity investment and M&A continued to reshape the pharmacy and infusion services sectors in the first quarter of 2019. Despite a recent wave of vertical integration between payors, PBMs and providers in the latter half of 2018, large-scale acquisitions have and will continue to occur as stakeholders expand their core competencies.
The Health-Care M&A Meter: Hot 2018 to Be Followed by Hotter 2019– The outlook for health-care mergers and acquisitions in 2019 suggests even more transactions this year as compared to 2018, with activity in the hospital and health system sector expected to continue, as well as increasing volume of deals in the physician services, home health. and health-care IT sectors.